Ambeed.cn

首页 / 抑制剂/激动剂 / 表观遗传学 / PRMT / TC-E 5003

TC-E 5003 {[allProObj[0].p_purity_real_show]}

货号:A169549 同义名: NSC 30176

TC-E 5003是一种选择性 PRMT1 抑制剂,对 hPRMT1 的 IC50 为 1.5 µM,还可调节 AP-1 和 NF-κB 信号通路,并具有抗炎特性。

TC-E 5003 化学结构 CAS号:17328-16-4
TC-E 5003 化学结构
CAS号:17328-16-4
TC-E 5003 3D分子结构
CAS号:17328-16-4
TC-E 5003 化学结构 CAS号:17328-16-4
TC-E 5003 3D分子结构 CAS号:17328-16-4
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

TC-E 5003 纯度/质量文件 产品仅供科研

货号:A169549 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

TC-E 5003 生物活性

描述 Protein arginine methyltransferase 1 (PRMT1) is a major type 1 arginine methyltransferase associated with the activation of estrogen and androgen receptors; therefore, may represent a therapeutic target for hormone-dependent cancers. TC-E 5003 is an inhibitor of PRMT1 with an IC50 value of 1.5±0.2µM. The GI50 value of TC-E 5003 for the growth of MCF7a and LNCaP cell lines are 1.97 ± 0.14 and 4.49 ± 0.14µM, respectively.[1] TC-E 5003 at concentrations of 0.125 – 1µM dose-dependently suppressed lipopolysaccharide-induced nitric oxide (NO) production in RAW264.7 cells. Treatment with TC-E 5003 also markedly reduced the expressions of inducible NO synthase, cyclooxygenase-2, tumor necrosis factor-α, interleukin (IL)-1β, and IL-6, and downregulated the nuclear translocation of nuclear factor kappa B subunits.[2] TC-E-5003 at a dose of 0.5mg exerted an anti-tumor effect (31.76%) in A549 tumor-bearing mice.[3]
作用机制 TC-E 5003 is a selective inhibitor of PRMT1.[1]

TC-E 5003 细胞实验

Cell Line
Concentration Treated Time Description References
RAW264.7 cells 0-1 µM 15 min TC-E inhibited c-Jun transcription in RAW264.7 cells after LPS treatment Int J Mol Sci. 2020 Apr 26;21(9):3058.
RAW264.7 cells 0-1 µM 15-30 min TC-E decreased p-c-Jun levels but did not affect phosphorylated MAPKs Int J Mol Sci. 2020 Apr 26;21(9):3058.
RAW264.7 cells 0-1 µM 15-60 min TC-E suppressed the nuclear translocation of NF-κB subunits p65 and p50 and AP-1 transcriptional factor c-Jun Int J Mol Sci. 2020 Apr 26;21(9):3058.
HEK293T cells 0-1 µM 24 hours TC-E did not alter Src phosphorylation in Src-overexpressing HEK293T cells Int J Mol Sci. 2020 Apr 26;21(9):3058.
RAW264.7 cells 0-1 µM 24 hours TC-E significantly reduced LPS-induced NO production without cytotoxicity Int J Mol Sci. 2020 Apr 26;21(9):3058.
RAW264.7 cells 0-1 µM 2-5 min TC-E inhibited Src phosphorylation after 2 min of LPS treatment but not Syk Int J Mol Sci. 2020 Apr 26;21(9):3058.
MDA-MB-231 0.5965 µM (IC50) 48 hours Evaluate the anti-tumor effect of TC-E-5003 on MDA-MB-231 cells, IC50 was 0.5965 μM. Drug Deliv. 2020 Dec;27(1):491-501.
MCF-7 0.4128 µM (IC50) 48 hours Evaluate the anti-tumor effect of TC-E-5003 on MCF-7 cells, IC50 was 0.4128 μM. Drug Deliv. 2020 Dec;27(1):491-501.
NCL-H1299 0.6844 µM (IC50) 48 hours Evaluate the anti-tumor effect of TC-E-5003 on NCL-H1299 cells, IC50 was 0.6844 μM. Drug Deliv. 2020 Dec;27(1):491-501.
A549 0.7022 µM (IC50) 48 hours Evaluate the anti-tumor effect of TC-E-5003 on A549 cells, IC50 was 0.7022 μM. Drug Deliv. 2020 Dec;27(1):491-501.
RAW264.7 cells 0-1 µM 5 min TC-E significantly downregulated IκBα phosphorylation after 5 min of LPS treatment Int J Mol Sci. 2020 Apr 26;21(9):3058.
RAW264.7 cells 0-1 µM 6 hours TC-E downregulated the expression of inflammatory genes (iNOS, COX-2, TNF-α, IL-6) Int J Mol Sci. 2020 Apr 26;21(9):3058.

TC-E 5003 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
ICR mice A549 cell xenograft model Subcutaneous injection 0.5 mg Single dose, lasting 28 days Evaluate the anti-tumor effect of TC-E-5003-INEI in A549 xenograft model, tumor inhibition efficiency was 68.23%. Drug Deliv. 2020 Dec;27(1):491-501.

TC-E 5003 参考文献

[1]Bissinger EM, Heinke R, Spannhoff A, Eberlin A, Metzger E, Cura V, Hassenboehler P, Cavarelli J, Schüle R, Bedford MT, Sippl W, Jung M. Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1. Bioorg Med Chem. 2011 Jun 15;19(12):3717-31. doi: 10.1016/j.bmc.2011.02.032

[2]Kim E, Jang J, Park JG, Kim KH, Yoon K, Yoo BC, Cho JY. Protein Arginine Methyltransferase 1 (PRMT1) Selective Inhibitor, TC-E 5003, Has Anti-Inflammatory Properties in TLR4 Signaling. Int J Mol Sci. 2020 Apr 26;21(9):3058. doi: 10.3390/ijms21093058

[3]Zhang P, Tao H, Yu L, Zhou L, Zhu C. Developing protein arginine methyltransferase 1 (PRMT1) inhibitor TC-E-5003 as an antitumor drug using INEI drug delivery systems. Drug Deliv. 2020 Dec;27(1):491-501. doi: 10.1080/10717544.2020.1745327

TC-E 5003 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.49mL

0.50mL

0.25mL

12.46mL

2.49mL

1.25mL

24.92mL

4.98mL

2.49mL

TC-E 5003 技术信息

CAS号17328-16-4
分子式C16H14Cl2N2O4S
分子量 401.26
SMILES Code O=S(C1=CC=C(NC(CCl)=O)C=C1)(C2=CC=C(NC(CCl)=O)C=C2)=O
MDL No. MFCD00028183
别名 NSC 30176
运输蓝冰
InChI Key SHRCVZJKZJGIHQ-UHFFFAOYSA-N
Pubchem ID 87052
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry,2-8°C

溶解方案

DMSO: 120 mg/mL(299.05 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。